Arcutis Biotherapeutics (ARQT) Receivables - Net (2022 - 2026)
Arcutis Biotherapeutics (ARQT) recorded Receivables - Net of $155.16 million in Q2 2026, up 45.4% from $106.69 million a year earlier and up 7.5% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Receivables - Net (2022 - 2026) Analysis & Trends
At the end of FY2025, Arcutis Biotherapeutics reported Receivables - Net of $146.23 million, up 100.1% from FY2024.
- Annual Receivables - Net has increased for three straight years, with a three-year compound annual growth rate of 158.6% (FY2022 to FY2025).
- Across earlier years, Receivables - Net came in at $73.07 million in FY2024 (+183.1%), $25.81 million in FY2023 (+205.1%) and $8.46 million in FY2022.
- The Q2 2026 figure is the highest quarterly Receivables - Net in data going back to Q3 2022.
- On a year-over-year basis, Receivables - Net has increased for 12 consecutive quarters, with growth averaging 121.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Receivables - Net ranged from 45.4% (Q2 2026) to 698.7% (Q3 2023).
- Per Business Quant, the preceding three quarters came in at $144.38 million (Q1 2026), $146.23 million (Q4 2025) and $115.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Arcutis Biotherapeutics | 4.24 Bn | 3.53 Bn | 118.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 155.16 Mn |
| Mar 31, 2026 | 144.38 Mn |
| Dec 31, 2025 | 146.23 Mn |
| Sep 30, 2025 | 115.12 Mn |
| Jun 30, 2025 | 106.69 Mn |
| Mar 31, 2025 | 85.42 Mn |
| Dec 31, 2024 | 73.07 Mn |
| Sep 30, 2024 | 60.12 Mn |
| Jun 30, 2024 | 43.41 Mn |
| Mar 31, 2024 | 37.15 Mn |
| Dec 31, 2023 | 25.81 Mn |
| Sep 30, 2023 | 19.42 Mn |
| Jun 30, 2023 | 17.21 Mn |
| Mar 31, 2023 | 12.77 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 2.43 Mn |
API Access
Arcutis Biotherapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();